Product Information
ETHOSUXIMIDE 250 MG/5 ML SOLN is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0893 per ML under NDC 59762235007. Its NADAC has been published 199 times since Sep 7, 2022.
The Low Outlier badge above means this manufacturer's average price in the Ethosuximide market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/5mL
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762235007
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA080258On Market Since
2/21/2020
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has been published 199 times since Sep 7, 2022, and over the history we have for it it has risen 21.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0893 per ML |
|---|---|
| All-time high | $0.0965 (Oct 15, 2025) |
| All-time low | $0.0631 (Apr 17, 2024) |
| 52-week high | $0.0965 |
| 52-week low | $0.0893 |
| Median price | $0.0859 |
| Average price | $0.0852 |
| Largest weekly change | +35.0% (Feb 26, 2025) |
| Weeks tracked | 199 |
| Tracking since | Sep 7, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG/5 ML SOLN, manufactured by Mylan Pharmaceuticals Inc., is $0.0893 per ML (NDC 59762235007), effective Jun 24, 2026.
How has the price of ETHOSUXIMIDE 250 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has risen 21.8%. It has been tracked across 199 weekly CMS publications since Sep 7, 2022.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG/5 ML SOLN?
Since Sep 7, 2022, the NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has ranged from a low of $0.0631 (Apr 17, 2024) to a high of $0.0965 (Oct 15, 2025), with a median of $0.0859 per ML.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG/5 ML SOLN?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ETHOSUXIMIDE 250 MG/5 ML SOLN, is $0.0780 per ML — about 13% below ETHOSUXIMIDE 250 MG/5 ML SOLN.
Who manufactures ETHOSUXIMIDE 250 MG/5 ML SOLN?
ETHOSUXIMIDE 250 MG/5 ML SOLN (NDC 59762235007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification